The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs), ...

Healthcare: Cancer is a heterogeneous and multifactorial disease. Among multiple factors, it may be caused by errors, or ...

The Human Genome Project should receive partial credit for giving us the technological advancement and innovation necessary ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

Global Cardiovascular Genetic Testing Market is valued at approximately USD 9.07 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period ...

Stay up to date with the latest news. Follow KT on WhatsApp Channels. Earlier, a top official had told Khaleej Times that ...

Black patients with inherited retinal diseases who undergo genetic testing are less likely than White patients to receive a ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

Genetic testing is a vital tool in combating hereditary gynecologic cancers, enabling early detection and personalised care.

According to a new market research report, 'Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis ...

was conducted on nearly 187,000 samples performed and across approximately 73,000 patients who received exome testing with ...